The genetic evolution of acral melanoma

• Published in: Nature communications Vol. 15; no. 1; pp. 6146 - 13
• Main Authors: Wang, Meng, Fukushima, Satoshi, Sheen, Yi-Shuan, Ramelyte, Egle, Cruz-Pacheco, Noel, Shi, Chenxu, Liu, Shanshan, Banik, Ishani, Aquino, Jamie D., Sangueza Acosta, Martin, Levesque, Mitchell, Dummer, Reinhard, Liau, Jau-Yu, Chu, Chia-Yu, Shain, A. Hunter, Yeh, Iwei, Bastian, Boris C.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 21.07.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 13/51; 14/32; 45/23; 631/208/69; 631/67/1813/1634; 631/67/2329; 631/80/103/560; 692/4028/67/1813/1634; Aberration; Chromosomes; Copy number; DNA Copy Number Variations; Evolution; Evolution & development; Evolution, Molecular; Exome Sequencing; Female; Gene sequencing; Heterogeneity; Humanities and Social Sciences; Humans; Kinases; Male; MAP Kinase Signaling System - genetics; Melanoma; Melanoma - genetics; Melanoma - pathology; multidisciplinary; Mutation; Science; Science (multidisciplinary); Skin Neoplasms - genetics; Skin Neoplasms - pathology; Telomerase; Telomerase - genetics; Whole genome sequencing
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-50233-z

Acral melanoma is an aggressive type of melanoma with unknown origins. It is the most common type of melanoma in individuals with dark skin and is notoriously challenging to treat. We examine exome sequencing data of 139 tissue samples, spanning different progression stages, from 37 patients. We find that 78.4% of the melanomas display clustered copy number transitions with focal amplifications, recurring predominantly on chromosomes 5, 11, 12, and 22. These complex genomic aberrations are typically shared across all progression stages of individual patients. TERT activating alterations also arise early, whereas MAP-kinase pathway mutations appear later, an inverted order compared to the canonical evolution. The punctuated formation of complex aberrations and early TERT activation suggest a unique mutational mechanism that initiates acral melanoma. The marked intratumoral heterogeneity, especially concerning MAP-kinase pathway mutations, may partly explain the limited success of therapies for this melanoma subtype. Understanding mutational processes and evolution in acral melanoma remains critical. Here, the authors sequence different progression stages of acral melanomas, finding early, punctuated emerging clusters of copy number alterations as well as inverted order in which telomerase and MAP-kinase pathway mutations arise, compared to other melanoma subtypes.